Introduction
VAPA, a type IV membrane protein, plays a crucial role in vesicle trafficking. It resides in the plasma membrane and intracellular vesicles, exhibiting connections with the cytoskeleton. This protein participates in various cellular processes, including membrane fusion, protein complex assembly, and cell motility. Notably, VAPA is essential for regulating the subcellular localization of protrudin and its influence on neurite outgrowth.
Description
Recombinant Human VAPA, produced in E. coli, is a single, non-glycosylated polypeptide chain comprising 264 amino acids (1-227 a.a.). With a molecular mass of 29.8 kDa, it is fused to a 37 amino acid His Tag and purified using proprietary chromatographic techniques.
Physical Appearance
A clear, colorless solution that has been sterilized through filtration.
Formulation
The VAPA solution is prepared with 20mM Tris buffer at pH 8, 1mM DTT (dithiothreitol), and 10% glycerol.
Stability
For short-term storage (2-4 weeks), the solution should be kept at 4°C. For longer periods, it's recommended to store it frozen at -20°C. Adding a carrier protein (0.1% HSA or BSA) is advised for long-term storage. Repeated freezing and thawing should be avoided.
Purity
SDS-PAGE analysis confirms a purity exceeding 85%.
Synonyms
hVAP-33, VAP-33, VAP-A, VAP33, Vesicle-associated membrane protein-associated protein A, VAMP-associated protein A, VAMP-A, 33 kDa VAMP-associated protein, VAPA.
Amino Acid Sequence
RGSHHHHHH GMASMTGGQQ MGRDLYDDDD KDRWGSHMAS ASGAMAKHEQ ILVLDPPTDL KFKGPFTDVV TTNLKLRNPS DRKVCFKVKT TAPRRYCVRP NSGIIDPGST VTVSVMLQPF DYDPNEKSKH KFMVQTIFAP PNTSDMEAVW KEAKPDELMD SKLRCVFEMP NENDKLNDME PSKAVPLNAS KQDGPMPKPH SVSLNDTETR KLMEECKRLQ GEMMKLSEEN RHLRDEGLRL RKVAHSDKPG STSTASFRDN VTSP.